Seller record · Telehealth service

NP2GO

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The pricing and weight loss program pages refer only to reputable pharmacy partners. 1 more criterion also fails; see the table below.

At a glance

NP2GOTelehealth service

6/8criteria passed
Price
Semaglutide from $150 a month plus a $99 provider visit every 3 months, or $199 a month on the membership; tirzepatide from $250
Sells
compounded semaglutide, compounded tirzepatide, sermorelin, and 3 more
FDA letters
None on file
Visit NP2GOSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A nurse-practitioner practice based in Edmond, Oklahoma that sells compounded semaglutide and tirzepatide by telehealth in 40 states, priced by dose on a pay-as-you-go plan or a flat monthly membership, along with sermorelin, NAD+ and hormone therapy. Every first-time patient meets a nurse practitioner by video before treatment.

Operating entity No legal entity name appears in the footer, on the contact page, on the about page or on the pricing page, and the privacy policy page carries no policy text.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSNP2GO's weight loss clinics page; NP2GO's FAQ; NP2GO's pricing page
S2Prescription gatingPASSNP2GO's website; NP2GO's FAQ; NP2GO's pricing page
S3Pharmacy identificationFAILNP2GO's pricing page; NP2GO's weight loss programs page
S4Compounding disclosurePASSNP2GO's pricing page; NP2GO's weight loss programs page
S5Analytical documentationFAILNP2GO's pricing page; NP2GO's weight loss programs page; NP2GO's FAQ
S6Business addressPASSNP2GO's contact page
S7Price disclosurePASSNP2GO's pricing page; NP2GO's weight loss programs page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAll care is provided by licensed nurse practitioners, the practice was founded by a family nurse practitioner licensed by the Oklahoma Board of Nursing, and each treatment plan follows a consultation in which the provider reviews the patient's history and goals.Source: NP2GO's weight loss clinics page; NP2GO's FAQ; NP2GO's pricing page.
S2PASSThe start buttons book an appointment, and the answers say the first visit is a face-to-face video appointment with a licensed nurse practitioner who discusses health history and treatment options. The pricing page says every treatment plan begins with a consultation.Source: NP2GO's website; NP2GO's FAQ; NP2GO's pricing page.
S3FAILNo filling pharmacy is named. The pricing and weight loss program pages refer only to reputable pharmacy partners.Source: NP2GO's pricing page; NP2GO's weight loss programs page.
S4PASSThe pricing page and the weight loss program page state that compounded semaglutide and tirzepatide are not FDA-approved.Source: NP2GO's pricing page; NP2GO's weight loss programs page.
S5FAILNo certificate of analysis or lot document is published on the pricing page, the weight loss pages or the answers.Source: NP2GO's pricing page; NP2GO's weight loss programs page; NP2GO's FAQ.
S6PASS800 W 18th St., Ste. 200 & 220, Edmond, Oklahoma 73013, printed on the contact page as the office for in-person visits, under the trade name NP2GO with a telephone number.Source: NP2GO's contact page.
S7PASSOn the pay-as-you-go plan, compounded semaglutide costs $150 to $350 a month and compounded tirzepatide $250 to $600 a month by dose, plus a $99 provider visit every 3 months. On the month-to-month membership, with no visit fee, semaglutide costs $199 a month for the first three doses and $299 after, and tirzepatide $299 and then $399. Sermorelin costs $250 a vial and NAD+ $200 a vial for home delivery.Source: NP2GO's pricing page; NP2GO's weight loss programs page.
S8PASSNo FDA warning letter names NP2GO, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+, testosterone replacement therapy, bioidentical hormone therapy.

Visit NP2GO

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.